INmune Bio Inc. (NASDAQ: INMB)
$9.32
-0.5400 ( -5.48% ) 27.7K
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.
Market Data
Open
$9.32
Previous close
$9.86
Volume
27.7K
Market cap
$184.27M
Day range
$9.30 - $9.89
52 week range
$6.50 - $14.74
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | May 16, 2024 |
| 4 | Insider transactions | 1 | May 16, 2024 |
| 4 | Insider transactions | 1 | May 16, 2024 |
| 4 | Insider transactions | 1 | May 16, 2024 |
| 4 | Insider transactions | 1 | May 16, 2024 |
| 4 | Insider transactions | 1 | May 16, 2024 |
| 8-k | 8K-related | 15 | May 16, 2024 |
| 8-k | 8K-related | 15 | May 13, 2024 |
| 10-q | Quarterly Reports | 65 | May 09, 2024 |
| 8-k | 8K-related | 15 | Apr 30, 2024 |